Meta-Analysis of Gene Expression Signatures Defining the Epithelial to Mesenchymal Transition during Cancer Progression

The epithelial to mesenchymal transition (EMT) represents a crucial event during cancer progression and dissemination. EMT is the conversion of carcinoma cells from an epithelial to a mesenchymal phenotype that associates with a higher cell motility as well as enhanced chemoresistance and cancer stemness. Notably, EMT has been increasingly recognized as an early event of metastasis. Numerous gene expression studies (GES) have been conducted to obtain transcriptome signatures and marker genes to understand the regulatory mechanisms underlying EMT. Yet, no meta-analysis considering the multitude of GES of EMT has been performed to comprehensively elaborate the core genes in this process. Here we report the meta-analysis of 18 independent and published GES of EMT which focused on different cell types and treatment modalities. Computational analysis revealed clustering of GES according to the type of treatment rather than to cell type. GES of EMT induced via transforming growth factor-β and tumor necrosis factor-α treatment yielded uniformly defined clusters while GES of models with alternative EMT induction clustered in a more complex fashion. In addition, we identified those up- and downregulated genes which were shared between the multitude of GES. This core gene list includes well known EMT markers as well as novel genes so far not described in this process. Furthermore, several genes of the EMT-core gene list significantly correlated with impaired pathological complete response in breast cancer patients. In conclusion, this meta-analysis provides a comprehensive survey of available EMT expression signatures and shows fundamental insights into the mechanisms that are governing carcinoma progression.

[1]  Shih-Hwa Chiou,et al.  SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. , 2011, Gastroenterology.

[2]  H. Ford,et al.  Eya2 Is Required to Mediate the Pro-Metastatic Functions of Six1 Via the Induction of TGF-β Signaling, Epithelial-Mesenchymal Transition, and Cancer Stem Cell Properties , 2011, Oncogene.

[3]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[4]  M. Levine,et al.  dorsal-twist interactions establish snail expression in the presumptive mesoderm of the Drosophila embryo. , 1992, Genes & development.

[5]  S. Ghatak,et al.  Elevated Hyaluronan Production Induces Mesenchymal and Transformed Properties in Epithelial Cells* , 2003, Journal of Biological Chemistry.

[6]  V. Keshamouni,et al.  Glycogene Expression Alterations Associated with Pancreatic Cancer Epithelial-Mesenchymal Transition in Complementary Model Systems , 2010, PloS one.

[7]  Georg Krupitza,et al.  Initial steps of metastasis: Cell invasion and endothelial transmigration , 2011, Mutation research.

[8]  Joaquín Dopazo,et al.  Babelomics: an integrative platform for the analysis of transcriptomics, proteomics and genomic data with advanced functional profiling , 2010, Nucleic Acids Res..

[9]  C. Edgell,et al.  Testican-1 inhibits attachment of Neuro-2a cells. , 2003, Matrix biology : journal of the International Society for Matrix Biology.

[10]  H. V. Jagadish,et al.  ConceptGen: a gene set enrichment and gene set relation mapping tool , 2010, Bioinform..

[11]  H. Saya,et al.  Tumor Necrosis Factor-α Regulates Transforming Growth Factor-β-dependent Epithelial-Mesenchymal Transition by Promoting Hyaluronan-CD44-Moesin Interaction* , 2009, The Journal of Biological Chemistry.

[12]  N. Brunskill,et al.  Proinsulin C-peptide antagonizes the profibrotic effects of TGF-beta1 via up-regulation of retinoic acid and HGF-related signaling pathways. , 2010, Molecular endocrinology.

[13]  G. Coetzee,et al.  Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis , 2010, Molecular Cancer.

[14]  J. Sallenave,et al.  Anti‐tumor effect of SLPI on mammary but not colon tumor growth , 2013, Journal of cellular physiology.

[15]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[16]  Yi Zhang,et al.  Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. , 2006, Cancer research.

[17]  Fan Zhang,et al.  A Pathway for the Control of Anoikis Sensitivity by E-Cadherin and Epithelial-to-Mesenchymal Transition , 2011, Molecular and Cellular Biology.

[18]  J. Chaudhary,et al.  2′‐5′ oligoadenylate synthetase 1 polymorphism is associated with prostate cancer , 2011, Cancer.

[19]  E. Neilson,et al.  Biomarkers for epithelial-mesenchymal transitions. , 2009, The Journal of clinical investigation.

[20]  E. Hay.  An overview of epithelio-mesenchymal transformation. , 1995, Acta anatomica.

[21]  P. Tan,et al.  Palladin, an actin-associated protein, is required for adherens junction formation and intercellular adhesion in HCT116 colorectal cancer cells. , 2010, International journal of oncology.

[22]  Kakajan Komurov,et al.  Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes , 2010, Proceedings of the National Academy of Sciences.

[23]  E. Diamandis,et al.  Pentraxin-3 Is a Novel Biomarker of Lung Carcinoma , 2011, Clinical Cancer Research.

[24]  Gerhard Christofori,et al.  Mechanisms of Motility in Metastasizing Cells , 2010, Molecular Cancer Research.

[25]  J. Pollack,et al.  LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer. , 2010, Cancer research.

[26]  Dawn R. Chin,et al.  Transforming Growth Factor-β1 Induces Heparan Sulfate 6-O-Endosulfatase 1 Expression in Vitro and in Vivo* , 2008, Journal of Biological Chemistry.

[27]  Françoise Seillier-Moiseiwitsch,et al.  Tumor Suppressor Function of Syk in Human MCF10A In Vitro and Normal Mouse Mammary Epithelium In Vivo , 2009, PloS one.

[28]  H. Ford,et al.  Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth. , 2010, Cancer research.

[29]  V. Rotter,et al.  TMPRSS2/ERG Promotes Epithelial to Mesenchymal Transition through the ZEB1/ZEB2 Axis in a Prostate Cancer Model , 2011, PloS one.

[30]  Y. Minami,et al.  Critical role of Wnt5a–Ror2 signaling in motility and invasiveness of carcinoma cells following Snail‐mediated epithelial–mesenchymal transition , 2011, Genes to cells : devoted to molecular & cellular mechanisms.

[31]  P. Grambsch,et al.  A Package for Survival Analysis in S , 1994 .

[32]  H. Sato,et al.  Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes. , 2001, Cancer research.

[33]  K. Dolinski,et al.  Use and misuse of the gene ontology annotations , 2008, Nature Reviews Genetics.

[34]  Xudong Wei,et al.  MEK Kinase 2 and the Adaptor Protein Lad Regulate Extracellular Signal-Regulated Kinase 5 Activation by Epidermal Growth Factor via Src , 2003, Molecular and Cellular Biology.

[35]  D. D. Billheimer,et al.  The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling. , 2009, The Journal of clinical investigation.

[36]  J. Ross,et al.  Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  Antoine M. van Oijen,et al.  Real-time single-molecule observation of rolling-circle DNA replication , 2009, Nucleic acids research.

[38]  Lilya V. Matyunina,et al.  Isolation and characterization of stem-like cells from a human ovarian cancer cell line , 2011, Molecular and Cellular Biochemistry.

[39]  David B Jackson,et al.  EMT is the dominant program in human colon cancer , 2011, BMC Medical Genomics.

[40]  Guanlin Wang,et al.  Secretory leukocyte protease inhibitor is associated with MMP-2 and MMP-9 to promote migration and invasion in SNU638 gastric cancer cells. , 2011, International journal of molecular medicine.

[41]  Stephanie Alexander,et al.  Cancer Invasion and the Microenvironment: Plasticity and Reciprocity , 2011, Cell.

[42]  H. Sugihara,et al.  Down-regulation of FXYD3 is induced by transforming growth factor-β signaling via ZEB1/δEF1 in human mammary epithelial cells. , 2011, Biological & pharmaceutical bulletin.

[43]  C. Pirker,et al.  A Human Model of Epithelial to Mesenchymal Transition to Monitor Drug Efficacy in Hepatocellular Carcinoma Progression , 2011, Molecular Cancer Therapeutics.

[44]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[45]  G. Landberg,et al.  Cyclin D1, Id1 and EMT in breast cancer , 2011, BMC Cancer.

[46]  Bing Zhang,et al.  WebGestalt: an integrated system for exploring gene sets in various biological contexts , 2005, Nucleic Acids Res..

[47]  K. Klinger,et al.  Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function , 2006, Molecular Cancer Therapeutics.

[48]  A. Morel,et al.  Antagonistic regulation of EMT by TIF1γ and Smad4 in mammary epithelial cells , 2011, EMBO reports.

[49]  M. Lenburg,et al.  Smad signaling is required to maintain epigenetic silencing during breast cancer progression. , 2010, Cancer research.

[50]  Christoph Wanner,et al.  Identification of a new tumor suppressor gene located at chromosome 8p21.3–22 , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[52]  V. Rotter,et al.  Reprogramming of cell junction modules during stepwise epithelial to mesenchymal transition and accumulation of malignant features in vitro in a prostate cell model. , 2011, Experimental cell research.

[53]  Gillian H. Little,et al.  Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2 , 2011, Breast Cancer Research.

[54]  Koichi Hirata,et al.  Gene expression analysis identifies over‐expression of CXCL1, SPARC, SPP1, and SULF1 in gastric cancer , 2010, Genes, chromosomes & cancer.

[55]  H. Sugihara,et al.  FXYD3 protein involved in tumor cell proliferation is overproduced in human breast cancer tissues. , 2009, Biological & pharmaceutical bulletin.

[56]  K. Hemminki,et al.  Consensus Pathways Implicated in Prognosis of Colorectal Cancer Identified Through Systematic Enrichment Analysis of Gene Expression Profiling Studies , 2011, PloS one.

[57]  E. Diamandis,et al.  Nidogen-2: a new serum biomarker for ovarian cancer. , 2010, Clinical biochemistry.

[58]  S. Bae,et al.  Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-β and bone morphogenetic protein , 2002, Oncogene.

[59]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[60]  C. Wu,et al.  Suppression of the invasion and migration of cancer cells by SERPINB family genes and their derived peptides. , 2011, Oncology reports.

[61]  A. Scorilas,et al.  Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancer , 2011, Tumor Biology.

[62]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[63]  P. Gimotty,et al.  A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors. , 2011, Cancer research.

[64]  E. Hay,et al.  The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

[65]  K. Chai,et al.  Loss of prostasin (PRSS8) in human bladder transitional cell carcinoma cell lines is associated with epithelial-mesenchymal transition (EMT) , 2009, BMC Cancer.

[66]  Thomas B Bair,et al.  ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells. , 2009, Molecular biology of the cell.

[67]  S. Wahl,et al.  Secretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinoma. , 2011, The American journal of pathology.

[68]  M. Bissell,et al.  Ionizing radiation predisposes nonmalignant human mammary epithelial cells to undergo transforming growth factor beta induced epithelial to mesenchymal transition. , 2007, Cancer research.